Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.

Yamada K, Yoshimura S, Kawasaki M, Enomoto Y, Asano T, Minatoguchi S, Iwama T.

Cerebrovasc Dis. 2009;28(4):417-24. doi: 10.1159/000235746. Epub 2009 Aug 26.

PMID:
19707015
2.

Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.

Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Gerasimidis T, Liapis CD.

J Vasc Surg. 2010 Jan;51(1):114-21. doi: 10.1016/j.jvs.2009.07.119. Epub 2009 Oct 17.

3.

Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.

Watanabe K, Sugiyama S, Kugiyama K, Honda O, Fukushima H, Koga H, Horibata Y, Hirai T, Sakamoto T, Yoshimura M, Yamashita Y, Ogawa H.

J Am Coll Cardiol. 2005 Dec 6;46(11):2022-30. Epub 2005 Nov 4.

4.

Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients.

Yamagami H, Sakaguchi M, Furukado S, Hoshi T, Abe Y, Hougaku H, Hori M, Kitagawa K.

Ultrasound Med Biol. 2008 Sep;34(9):1353-9. doi: 10.1016/j.ultrasmedbio.2008.01.019. Epub 2008 Apr 18.

PMID:
18378381
5.

The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study.

Della-Morte D, Moussa I, Elkind MS, Sacco RL, Rundek T.

Neurol Res. 2011 Nov;33(9):991-4. doi: 10.1179/1743132811Y.0000000039.

6.

Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.

Kadoglou NP, Gerasimidis T, Kapelouzou A, Moumtzouoglou A, Avgerinos ED, Kakisis JD, Karayannacos PE, Liapis CD.

Eur J Vasc Endovasc Surg. 2010 Mar;39(3):258-65. doi: 10.1016/j.ejvs.2009.11.013. Epub 2009 Dec 8.

7.

MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.

Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek MB, Polissar N, Monick D, Lee C, Underhill H, Yuan C.

JACC Cardiovasc Imaging. 2011 Sep;4(9):977-86. doi: 10.1016/j.jcmg.2011.06.013.

8.

Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty.

Kougialis S, Skopelitis E, Gialernios T, Nikolaou S, Kroustalis A, Katsadorou E, Gialernios K, Zervou A, Gika E, Polydorou A, Polydorou V, Drakoulis C, Iliopoulos N, Dermitzakis I, Mpilinis H, Polydorou A.

Int Angiol. 2010 Aug;29(4):338-47.

PMID:
20671652
9.

Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.

Yokoyama M, Komiyama N, Courtney BK, Nakayama T, Namikawa S, Kuriyama N, Koizumi T, Nameki M, Fitzgerald PJ, Komuro I.

Am Heart J. 2005 Aug;150(2):287.

PMID:
16086932
10.

Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.

Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G.

Ultrasound Med Biol. 2009 Nov;35(11):1763-72. doi: 10.1016/j.ultrasmedbio.2009.05.017. Epub 2009 Aug 3.

PMID:
19647921
11.

Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.

Marchione P, Vento C, Morreale M, Izzo C, Maugeri A, Manuppella F, Romeo T, Giacomini P.

J Stroke Cerebrovasc Dis. 2015 Jan;24(1):138-43. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.006. Epub 2014 Oct 22.

PMID:
25440329
12.

Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.

Kadoglou NP, Gerasimidis T, Moumtzouoglou A, Kapelouzou A, Sailer N, Fotiadis G, Vitta I, Katinios A, Kougias P, Bandios S, Voliotis K, Karayannacos PE, Liapis CD.

Eur J Vasc Endovasc Surg. 2008 Jun;35(6):661-8. doi: 10.1016/j.ejvs.2007.12.011. Epub 2008 Apr 18.

13.
14.

One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.

Avellone G, Di Garbo V, Abruzzese G, Campisi D, De Simone R, Raneli G, Licata G.

Int Angiol. 2006 Mar;25(1):26-34.

15.

Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.

Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):222-8. doi: 10.1097/HJR.0b013e32832948a0.

PMID:
19242355
16.
18.

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators.

Stroke. 2008 Dec;39(12):3297-302. doi: 10.1161/STROKEAHA.108.516450. Epub 2008 Oct 9.

19.

Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness.

Migrino RQ, Bowers M, Harmann L, Prost R, LaDisa JF Jr.

J Cardiovasc Magn Reson. 2011 Aug 3;13:37. doi: 10.1186/1532-429X-13-37.

20.

Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.

Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE.

Circulation. 2006 Jun 20;113(24):2826-34. Epub 2006 Jun 12.

Supplemental Content

Support Center